Terumo (OTCMKTS:TRUMY) Shares Gap Down – Should You Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down prior to trading on Friday. The stock had previously closed at $15.4880, but opened at $14.7001. Terumo shares last traded at $15.21, with a volume of 67,929 shares trading hands.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on TRUMY. Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. Zacks Research upgraded Terumo from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 13th. Two research analysts have rated the stock with a Strong Buy rating. According to data from MarketBeat.com, the company has a consensus rating of “Strong Buy”.

Terumo Trading Down 2.0%

The company has a quick ratio of 1.37, a current ratio of 2.19 and a debt-to-equity ratio of 0.13. The firm has a market cap of $22.39 billion, a price-to-earnings ratio of 21.38 and a beta of 0.77. The business’s fifty day moving average is $14.99 and its two-hundred day moving average is $14.29.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings data on Friday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.13. Terumo had a return on equity of 10.44% and a net margin of 13.83%. The firm had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.84 billion. Equities analysts anticipate that Terumo Corp. will post 0.86 earnings per share for the current fiscal year.

Terumo Company Profile

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells medical devices and healthcare products. Its offerings support hospitals, physicians and other healthcare providers across areas including cardiovascular care, interventional procedures, blood management, cell and gene therapies, and general medical care.

The company’s products include catheters, guidewires, stents and other devices used in cardiovascular and endovascular procedures, as well as blood bags, apheresis systems, cell-processing technologies, infusion and injection products, and hospital equipment.